Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Frontiers in Pharmacology|June 15, 2026
Very strong correlations of metoprolol- and solanidine-derived metabolic ratios in a real-world cohort with a stable metoprolol drug regimenJens Andreas Sarömba, Berkan Kurt, Alessandra Antwerpen, et al.
Cancers|August 7, 2021
The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic CholangiocarcinomaJan Bednarsch, Xiuxiang Tan, Zoltan Czigany, et al.
Molecular Cancer|February 25, 2017
ITIH5 mediates epigenetic reprogramming of breast cancer cellsMichael Rose, Vera Kloten, Erik Noetzel, et al.
Clinical Kidney Journal|January 10, 2025
Proenkephalin A 119-159 (penKid) and mortality in stable patients at high cardiovascular riskMatthias Rau, Berkan Kurt, Oliver Hartmann, et al.
European Journal of Human Genetics : EJHG|May 25, 2021
Stakeholder engagement to ensure the sustainability of biobanks: a survey of potential users of biobank servicesCorinna Klingler, Magdaléna von Jagwitz-Biegnitz, Ronny Baber, et al.
The Journal of Biological Chemistry|September 21, 2011
Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?Glen Kristiansen, Junmin Hu, Daniela Wichmann, et al.
Journal of Cellular and Molecular Medicine|February 27, 2008
Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profilingChristian Pilarsky, Ole Ammerpohl, Bence Sipos, et al.
Molecular Oncology|February 20, 2024
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migrationJennifer Kosinski, Antonio Sechi, Johanna Hain, et al.
Atherosclerosis|May 31, 2025
Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVDBerkan Kurt, Matthias Rau, Oliver Hartmann, et al.
Pageof 14